Filtered By:
Infectious Disease: Coronavirus

This page shows you your search results in order of date. This is page number 10.

Order by Relevance | Date

Total 2387 results found since Jan 2013.

Preference for and impact of telehealth vs in-person asthma visits among Black and Latinx adults
Black and Latinx adults experience disproportionate asthma-related morbidity and limited specialty care access. The severe acute respiratory syndrome coronavirus 2 pandemic expanded telehealth use.
Source: Annals of Allergy, Asthma and Immunology - July 23, 2023 Category: Allergy & Immunology Authors: Israel C. Ugalde, Amanda Ratigan, Conner Merriman, Jing Cui, Brianna Ericson, Paula Busse, Jennifer K. Carroll, Thomas Casale, Juan Carlos Celed ón, Tamera Coyne-Beasley, Maureen Fagan, Anne L. Fuhlbrigge, Gabriela Gaona Villarreal, Paulina Arias Hernand Source Type: research

The Direct Impact of the COVID ‐19 Pandemic on Rhinology Practice
ConclusionsCOVID-19 significantly affected the number of patients seen, virtual visit encounters, nasal endoscopies, and imaging utilization. Further research is needed to determine if patient outcomes were impacted and if these changes in practice will persist.This article is protected by copyright. All rights reserved
Source: International Forum of Allergy and Rhinology - July 22, 2023 Category: Allergy & Immunology Authors: Sarah R. Sutton, April Taniguchi, Shaun A. Nguyen, Zachary M. Soler, Rodney J. Schlosser Tags: CLINICAL LETTER Source Type: research

Explainer: Why the U.S. has banned funding for Chinese lab at center of pandemic origin dispute
In a move that has more symbolic than practical impact, the U.S. Department of Health and Human Services (HHS) has imposed new sanctions on a Chinese lab at the center of the debate about the origin of the COVID-19 pandemic. A nine-page HHS memo made public by a House subcommittee that ’s investigating the pandemic ’s origin suspends and proposes debarment of the Wuhan Institute of Virology (WIV) “from participating in United States Federal Government procurement and nonprocurement programs.” In effect, this bars WIV from receiving U.S. government funding now and possibly ever. The ...
Source: ScienceNOW - July 20, 2023 Category: Science Source Type: news

Politicians, scientists spar over alleged NIH cover-up using COVID-19 origin paper
Two scientists who are coauthors of a 3-year-old article on the origin of the COVID-19 pandemic faced down Republican lawmakers today in what might be the most in-depth discussion ever of a scientific paper in the halls of the U.S. Congress. At a House subcommittee hearing , the Republicans asserted that top officials at the U.S. National Institutes of Health (NIH) prompted the researchers to write the paper to try and “kill” the theory that SARS-CoV-2 leaked from a laboratory in Wuhan, China. The scientists, two of its five co-authors, flatly rejected the allegation. And as the hearing extended over 3 hours, com...
Source: Science of Aging Knowledge Environment - July 11, 2023 Category: Geriatrics Source Type: research

The U.S. Scientist At the Heart of COVID-19 Lab Leak Conspiracies Is Still Trying to Save the World From the Next Pandemic
Ralph Baric stepped onto the auditorium stage at the University of North Carolina, Chapel Hill, and looked out at the sparse audience that had come to hear him speak. On the large projector screen hanging behind him, the following words appeared: How Bad the Next Pandemic Could Be, What Might It Look Like, and Will We be Ready. The date was May 29, 2018. “Well, I have to admit I’m a little worried about giving this talk,” Baric said. “The reason is being labelled a harbinger of doom.” The screen shifted, and images of the four horsemen of the apocalypse—Death, Famine, War, and Plague&mda...
Source: TIME: Health - July 11, 2023 Category: Consumer Health News Authors: Dan Werb Tags: Uncategorized COVID-19 feature freelance Source Type: news

Causal relationship between asthma-related diseases and the risk of COVID-19: A  2-sample mendelian randomization study
We read with interest the study recently published by Skevaki et  al1 in the Journal of Allergy and Clinical Immunology. Skevaki et al1 found that the differences in risk associated with coronavirus disease 2019 (COVID-19) that are observed in patients with asthma are associated with different prevalence of underlying comorbidities, particularly, chronic obstru ctive pulmonary disease (COPD). However, inconsistent associations between asthma and COVID-19 disease have been observed in epidemiology studies.
Source: Journal of Allergy and Clinical Immunology - July 10, 2023 Category: Allergy & Immunology Authors: Shu Ran, XinHong Qiu, BaoLin Liu Tags: Correspondence Source Type: research

The Use and Teaching of Telemedicine in Allergy/Immunology Training Programs
AbstractPurpose of ReviewThe use of telemedicine has greatly increased since the onset of the coronavirus disease 2019 (COVID-19) pandemic. This review discusses the types of telemedicine, current telehealth curricula in medical education, and benefits and disadvantages of incorporation of telemedicine into Allergy/Immunology training programs.Recent FindingsThe majority of Allergists/Immunologists use telemedicine in their clinical practice with leaders in graduate medical education recommending inclusion of telemedicine in training. Fellows-in-training reported that use of telemedicine in Allergy/Immunology training duri...
Source: Current Allergy and Asthma Reports - July 7, 2023 Category: Allergy & Immunology Source Type: research

Intranasal steroid use and COVID-19 mortality among patients with asthma and COPD
Systemic corticosteroids have been widely used for treating patients with severe acute respiratory distress syndrome. Inhaled corticosteroids may have a protective effect for treating acute coronavirus disease 2019 (COVID-19); however, little is known about the potential effect of intranasal corticosteroids (INCS) on COVID-19 outcomes and severity.
Source: Annals of Allergy, Asthma and Immunology - July 4, 2023 Category: Allergy & Immunology Authors: Virginia Hernandez Santiago, Adeniyi Francis Fagbamigbe, Frank M Sullivan, Utkarsh Agrawal, Daniel Morales, Colin McCowan, Brian Lipworth Tags: Original Article Source Type: research

COVID-19, Coronavirus Vaccines, and Possible Association with Lipsch ütz Vulvar Ulcer: A Systematic Review
In conclusion, COVID-19 and immunization against SARS-CoV-2 add to Epstein-Barr virus as plausible triggers of Lipschütz genital ulcer.
Source: Clinical Reviews in Allergy and Immunology - June 26, 2023 Category: Allergy & Immunology Source Type: research

Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients
Vaccine. 2023 Jun 15:S0264-410X(23)00714-4. doi: 10.1016/j.vaccine.2023.06.039. Online ahead of print.ABSTRACTBasophil activation test (BAT) can tackle multiple mechanisms underlying acute and delayed hypersensitivity to drugs and vaccines and might complement conventional allergy diagnostics but its role in anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine-related hypersensitivity is ill-defined. Therefore, 89 patients with possible hypersensitivity (56 % with delayed mucocutaneous manifestations) to anti-SARS-CoV-2 vaccines were tested with BAT for Macrogol 3350, DMG-PEG 2000, PEG 20000, polysorba...
Source: Vaccine - June 22, 2023 Category: Allergy & Immunology Authors: Patrizia Pignatti Giuseppe Alvise Ramirez Marco Russo Paolo Marraccini Serena Nannipieri Chiara Asperti Fabrizio Della Torre Antonio Tiri Beatrice Maria Gatti Antonella Gurrado Antonio Meriggi Giovanni Benanti Maria Bernadette Cilona Paolo Pigatto Samuele Source Type: research

Controller therapy attenuates asthma exacerbations associated with prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children
Nearly 80% of asthma exacerbations are associated with viral respiratory infections.1 The first cases of coronavirus disease 2019 (COVID-19) because of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in late December 2019 in Wuhan, People's Republic of China, and was first reported in the United States in January 2020.2
Source: Annals of Allergy, Asthma and Immunology - June 12, 2023 Category: Allergy & Immunology Authors: Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant Tags: Letters Source Type: research

Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children
Abbreviations: Coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2), inhaled corticosteroids (ICS), oral corticosteroid (OCS), short-acting beta-agonist (SABA), long-acting beta-agonist (LABA), leukotriene receptor antagonist (LTRA), rate ratios (RR), polymerase chain reaction (PCR)
Source: Annals of Allergy, Asthma and Immunology - June 12, 2023 Category: Allergy & Immunology Authors: Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant Tags: Letters Source Type: research

Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A  GRADE assessment and international consensus approach
This guidance updates 2021 GRADE (Grading of Recommendations Assessment, Development and Evaluation) recommendations regarding immediate allergic reactions following coronavirus disease 2019 (COVID-19) vaccines and addresses revaccinating individuals with first-dose allergic reactions and allergy testing to determine revaccination outcomes. Recent meta-analyses assessed the incidence of severe allergic reactions to initial COVID-19 vaccination, risk of mRNA-COVID-19 revaccination after an initial reaction, and diagnostic accuracy of COVID-19 vaccine and vaccine excipient testing in predicting reactions.
Source: Journal of Allergy and Clinical Immunology - June 7, 2023 Category: Allergy & Immunology Authors: Matthew Greenhawt, Timothy E. Dribin, Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David B.K. Golden, Cem Akin, Akterini Anagnostou, Faisal ALMuhizi, Waleed Alqurashi, Peter Arkwright, James L. Baldwin, Aleena Banerji, Philippe B égin, Moshe Ben-Shosha Tags: Review article Source Type: research

We May Need a New Defense Against New COVID Variants We May Need a New Defense Against New COVID Variants
New human monoclonal antibodies that target the host, rather than the virus, effectively prevent infection and could provide a pathway toward protection against future coronaviruses.Medscape Medical News
Source: Medscape Allergy Headlines - June 1, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news